chr11:69641156:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr11:69,455,924-69,469,242 |
hg38 | chr11:69,641,156-69,654,474 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.084 | squamous cell carcinoma | Cyclin D1 overexpression is associated with poor clinicopathological outcome and... | BeFree,GAD,LHGDN | 24675814 | Detail |
0.084 | squamous cell carcinoma | Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their ... | BeFree,GAD,LHGDN | 25645517 | Detail |
0.204 | Carcinoma, Transitional Cell | Given that the tumor-promoting inflammation has been previously established in s... | BeFree,CTD_human,LHGDN,RGD | 24448750 | Detail |
<0.001 | carcinosarcoma | NA | BeFree | Detail | |
0.120 | Cecal Neoplasms | NA | CTD_human | Detail | |
0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
<0.001 | cerebral palsy | NA | BeFree | Detail | |
0.006 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.005 | Uterine Cervical Neoplasm | NA | BeFree,GAD | Detail | |
<0.001 | chondrosarcoma | NA | BeFree | Detail | |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
0.003 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
0.122 | Colonic Neoplasms | NA | BeFree,CTD_human | Detail | |
0.017 | colorectal carcinoma | The elevated expression of ATG4B was highly correlated with CCND1 expression, co... | BeFree | 24991826 | Detail |
0.017 | colorectal carcinoma | Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorecta... | BeFree | 25146682 | Detail |
0.017 | colorectal carcinoma | Treatment with ganetespib (50 nM) for 24 hours inhibited cyclin D1 and pRb at th... | BeFree | 25296971 | Detail |
0.017 | colorectal carcinoma | Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of t... | BeFree | 25479723 | Detail |
0.017 | colorectal carcinoma | The significant association of CCND1 genotypes with colorectal cancer in Taiwan. | BeFree | 25809706 | Detail |
0.017 | colorectal carcinoma | Additionally, CCND1 (cyclin D1), and PTGS2 (prostaglandin-endoperoxide synthase ... | BeFree | 25818893 | Detail |
0.017 | colorectal carcinoma | The quantitative level of the β-catenin protein was significantly decreased in t... | BeFree | 26316447 | Detail |
0.150 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Coxsackievirus Infections | NA | BeFree | Detail | |
<0.001 | craniosynostosis | In conclusion, the expression of Cav-1 was downregulated in CRS and the role of ... | BeFree | 24943192 | Detail |
0.002 | Crohn Disease | NA | GAD | Detail | |
0.123 | adenoid cystic carcinoma | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Phyllodes Tumor | NA | BeFree | Detail | |
<0.001 | Mental Depression | Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to ... | BeFree | 25358426 | Detail |
<0.001 | depressive disorder | Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to ... | BeFree | 25358426 | Detail |
0.002 | DNA Damage | NA | GAD | Detail | |
<0.001 | Down syndrome | NA | BeFree | Detail | |
<0.001 | Drug abuse | NA | BeFree | Detail | |
<0.001 | Dwarfism | NA | BeFree | Detail | |
0.013 | Endometrial Neoplasms | NA | GAD,LHGDN | Detail | |
0.003 | endometriosis | NA | BeFree,LHGDN | Detail | |
<0.001 | Epithelial hyperplasia | NA | BeFree | Detail | |
0.146 | Esophageal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Fatigue | NA | BeFree | Detail | |
<0.001 | Fatty Liver | NA | BeFree | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
0.001 | fibrosarcoma | NA | BeFree | Detail | |
0.003 | Fibrosis | NA | LHGDN | Detail | |
<0.001 | ganglioneuroma | NA | BeFree | Detail | |
0.003 | gastritis | NA | BeFree,GAD | Detail | |
0.003 | gastroesophageal reflux disease | NA | BeFree,GAD | Detail | |
<0.001 | Giant Cell Tumors | NA | BeFree | Detail | |
0.008 | glioblastoma | NA | BeFree,LHGDN | Detail | |
<0.001 | goiter | NA | BeFree | Detail | |
<0.001 | nodular goiter | NA | BeFree | Detail | |
0.003 | Giant Cell Granuloma | NA | LHGDN | Detail | |
<0.001 | Hamartoma | NA | BeFree | Detail | |
0.008 | Head and Neck Neoplasms | The mitotic index and immunoreactivity of NF-kB, phospho-IkB, and cyclin D1 in t... | BeFree,GAD,LHGDN | 25454347 | Detail |
0.003 | Heart Neoplasm | NA | LHGDN | Detail | |
<0.001 | hemangioma | NA | BeFree | Detail | |
0.120 | Hemangiosarcoma | NA | CTD_human | Detail | |
0.003 | Hemophilia A | NA | BeFree,GAD | Detail | |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.123 | Von Hippel-Lindau syndrome | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
0.001 | Hodgkin Disease | NA | BeFree | Detail | |
<0.001 | Huntington disease | NA | BeFree | Detail | |
<0.001 | hyperglycemia | NA | BeFree | Detail | |
0.124 | hyperparathyroidism | NA | BeFree,CTD_human,LHGDN | Detail | |
0.125 | Hyperplasia | NA | CTD_human,LHGDN | Detail | |
<0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
0.006 | Inflammatory Bowel Diseases | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Intestinal Neoplasms | NA | BeFree | Detail | |
0.120 | Intestinal Polyps | NA | BeFree,CTD_human | Detail | |
0.003 | keratoacanthoma | NA | LHGDN | Detail | |
0.003 | keratosis | NA | LHGDN | Detail | |
0.002 | Kidney Failure, Chronic | NA | GAD | Detail | |
0.121 | Kidney Neoplasm | NA | BeFree,CTD_human | Detail | |
0.002 | Laryngeal Diseases | NA | GAD | Detail | |
0.005 | Laryngeal neoplasm | NA | BeFree,GAD,LHGDN | Detail | |
0.008 | Fibroid Tumor | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | leiomyosarcoma | NA | BeFree | Detail | |
0.128 | leukemia | NA | BeFree,CTD_human,GAD | Detail | |
0.256 | chronic lymphocytic leukemia | NA | BeFree,CTD_human,GAD,ORPHANET | Detail | |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
0.007 | hairy cell leukemia | NA | BeFree,LHGDN | Detail | |
<0.001 | lymphoid leukemia | NA | BeFree | Detail | |
0.003 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.004 | myeloid leukemia | NA | BeFree,LHGDN | Detail | |
<0.001 | Leukemia, Myeloid, Accelerated Phase | NA | BeFree | Detail | |
0.004 | Myeloid Leukemia, Chronic | Activation of FOXO1 and 3a and a decreased expression of their target gene Cycli... | BeFree,LHGDN | 24806995 | Detail |
<0.001 | Leukemia, Plasma Cell | NA | BeFree | Detail | |
<0.001 | prolymphocytic leukemia | NA | BeFree | Detail | |
0.003 | Leukemia, T-Cell | NA | LHGDN | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | Leukoencephalopathy, Progressive Multifocal | NA | BeFree | Detail | |
0.003 | Leukoplakia, Oral | NA | BeFree,GAD | Detail | |
<0.001 | Lichen Sclerosus et Atrophicus | NA | BeFree | Detail | |
<0.001 | Hyperlipoproteinemia Type I | NA | BeFree | Detail | |
<0.001 | liposarcoma | NA | BeFree | Detail | |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
0.006 | Liver neoplasms | Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells... | BeFree,GAD | 25385370 | Detail |
0.080 | Liver Neoplasms, Experimental | NA | RGD | Detail | |
0.003 | Chronic Obstructive Airway Disease | In addition, we determined the expression patterns of connective tissue growth f... | BeFree,GAD | 25708588 | Detail |
0.137 | Lung Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.002 | Lymphatic Metastasis | NA | GAD | Detail | |
<0.001 | Lymphocytosis | NA | BeFree | Detail | |
0.031 | lymphoma | Two cyclin D1-positive lymphomas with morphologic features of DLBCL and IGH-CCND... | BeFree,LHGDN | 25596256 | Detail |
0.006 | Lymphoma, Follicular | We present here a unique case of follicular lymphoma (FL) with rearranged BCL2, ... | BeFree,GAD | 25953460 | Detail |
<0.001 | Small Cell Lymphoma | NA | BeFree | Detail | |
0.010 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | Lymphoproliferative Disorders | NA | BeFree | Detail | |
<0.001 | Waldenstrom Macroglobulinemia | NA | BeFree | Detail | |
0.012 | Malignant neoplasm of stomach | In conclusion, this CagA- PI3K/AKT-Sp1-RBP2-Cyclin D1 pathway may serve as a nov... | BeFree,GAD | 25015565 | Detail |
0.012 | Malignant neoplasm of stomach | To examine the expression patterns of ER-α36 and Cyclin D1 in human gastric canc... | BeFree,GAD | 25231129 | Detail |
0.012 | Malignant neoplasm of stomach | Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric c... | BeFree,GAD | 25337233 | Detail |
0.012 | Malignant neoplasm of stomach | Moreover, the expression of WISP3 was positively correlated with the expression ... | BeFree,GAD | 25400723 | Detail |
0.012 | Malignant neoplasm of stomach | Fz2 shRNA suppressed cell proliferation and motility of MKN45 and MKN74 cells, a... | BeFree,GAD | 25586465 | Detail |
0.120 | Animal Mammary Neoplasms | NA | CTD_human | Detail | |
0.200 | Mammary Neoplasms, Experimental | NA | CTD_human,RGD | Detail | |
0.001 | medulloblastoma | NA | BeFree | Detail | |
0.021 | melanoma | FISH analysis of human acral melanoma expanding in the epidermis revealed that u... | BeFree,LHGDN | 25065272 | Detail |
0.001 | multiple endocrine neoplasia type 1 | NA | BeFree | Detail | |
0.011 | meningioma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
0.003 | Mixed Salivary Gland Tumor | NA | BeFree,LHGDN | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
<0.001 | Monosomy | NA | BeFree | Detail | |
0.018 | Mouth Neoplasms | An association between CCND1 overexpression in oral tumors and poor prognosis ha... | BeFree,GAD,LHGDN | 24809775 | Detail |
0.397 | multiple myeloma | We showed tetraspanins attenuated peIF4E and its targets [c‑Myc, cyclin D1 (cycD... | BeFree,CTD_human,GWASCAT,LHGDN,ORPHANET | 25422161 | Detail |
0.397 | multiple myeloma | Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apop... | BeFree,CTD_human,GWASCAT,LHGDN,ORPHANET | 25881299 | Detail |
<0.001 | Mycoses | NA | BeFree | Detail | |
<0.001 | mycosis fungoides | NA | BeFree | Detail | |
<0.001 | myocardial infarction | NA | BeFree | Detail | |
0.002 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
<0.001 | Neck Neoplasms | NA | BeFree | Detail | |
0.026 | Neoplasm Metastasis | Head and neck squamous cell carcinoma (HNSCC) progression and metastasis have pr... | BeFree,GAD,LHGDN | 23730900 | Detail |
0.026 | Neoplasm Metastasis | The pooled results provided compelling evidence that cyclin D1 overexpression wa... | BeFree,GAD,LHGDN | 24675814 | Detail |
0.026 | Neoplasm Metastasis | RKIP expression in gastric cancer was negatively correlated with the invasion, T... | BeFree,GAD,LHGDN | 25337233 | Detail |
0.026 | Neoplasm Metastasis | To elucidate the underlying molecular mechanisms produced by these EDC, alterati... | BeFree,GAD,LHGDN | 25849766 | Detail |
0.026 | Neoplasm Metastasis | Our results suggest that the CCND1 A870G polymorphism might not be a potential c... | BeFree,GAD,LHGDN | 25888980 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.120 | Neoplasms, Experimental | NA | CTD_human | Detail | |
<0.001 | multiple endocrine neoplasia | NA | BeFree | Detail | |
<0.001 | nephroblastoma | Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and meta... | BeFree | 25751590 | Detail |
<0.001 | nephrotic syndrome | NA | BeFree | Detail | |
<0.001 | neurilemmoma | NA | BeFree | Detail | |
0.006 | neuroblastoma | Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other... | BeFree,LHGDN | 25751590 | Detail |
0.003 | acoustic neuroma | NA | BeFree,GAD | Detail | |
<0.001 | Nevus | NA | BeFree | Detail | |
0.001 | Melanocytic nevus | NA | BeFree | Detail | |
0.001 | obesity | NA | BeFree | Detail | |
0.003 | osteosarcoma | β-catenin protein expression was, however, detected in the membrane and cytoplas... | BeFree | 24942472 | Detail |
0.003 | osteosarcoma | When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was dow... | BeFree | 25530340 | Detail |
0.003 | osteosarcoma | The cyclin D1 expression was significantly decreased following the treatment wit... | BeFree | 26434118 | Detail |
0.006 | ovarian carcinoma | The down regulation of β-catenin and cyclin-D1 in the tumor tissues may refer to... | BeFree | 24444073 | Detail |
0.006 | ovarian carcinoma | The cyclin D1 expression was significantly decreased following the treatment wit... | BeFree | 26434118 | Detail |
<0.001 | Ovarian Diseases | NA | BeFree | Detail | |
0.004 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
0.120 | papilloma | NA | BeFree,CTD_human | Detail | |
<0.001 | paraganglioma | Discordant results were observed for VEGFR1, p27, and p21 overexpressed in parag... | BeFree | 24390213 | Detail |
<0.001 | Parathyroid Diseases | NA | BeFree | Detail | |
0.007 | Parathyroid Neoplasms | While bi-allelic inactivation of CDC73/HRPT2 seems unique to parathyroid maligna... | BeFree,LHGDN | 26163537 | Detail |
<0.001 | Peyronie Disease | We observed that Ad-HDAC2 shRNA decreased inflammatory cell infiltration, reduce... | BeFree | 24841412 | Detail |
<0.001 | Peyronie Disease | Overexpression of the SMAD7 gene decreased the expression of cyclin D1 (a positi... | BeFree | 25532569 | Detail |
0.003 | Peptic Ulcer | NA | BeFree,GAD | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
0.001 | Pituitary Diseases | NA | BeFree | Detail | |
0.006 | Pituitary Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | plague | NA | BeFree | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
0.008 | Adenomatous Polyposis Coli | NA | BeFree,LHGDN | Detail | |
<0.001 | polyps | NA | BeFree | Detail | |
0.130 | Precancerous Conditions | Further studies in premalignant bronchial cells showed that the antiproliferativ... | BeFree,CTD_human,GAD | 25896445 | Detail |
<0.001 | prolactinoma | NA | BeFree | Detail | |
0.217 | Prostatic Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
<0.001 | psoriasis | NA | BeFree | Detail | |
0.080 | Reperfusion Injury | NA | RGD | Detail | |
0.020 | retinoblastoma | Following further examination of cell cycle-related factors, MCM2 knockdown inhi... | BeFree,LHGDN | 25738322 | Detail |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
0.120 | Salivary Gland Neoplasms | NA | CTD_human | Detail | |
<0.001 | Kaposi sarcoma | NA | BeFree | Detail | |
0.080 | Seizures | NA | RGD | Detail | |
<0.001 | Sertoli cell tumor | NA | BeFree | Detail | |
<0.001 | Sezary syndrome | NA | BeFree | Detail | |
0.001 | Skin Neoplasms | NA | BeFree | Detail | |
<0.001 | Soft Tissue Neoplasms | NA | BeFree | Detail | |
0.141 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | gastric ulcer | RKIP, STAT3 and cyclin D1 proteins were detected by immunohistochemistry in tiss... | BeFree | 25337233 | Detail |
0.002 | synovial sarcoma | NA | BeFree | Detail | |
0.003 | Thrombocythemia, Essential | NA | LHGDN | Detail | |
<0.001 | thymoma | NA | BeFree | Detail | |
<0.001 | Thymus Hyperplasia | NA | BeFree | Detail | |
0.135 | Thyroid Neoplasm | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | Chromosomal translocation | NA | GAD | Detail | |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
0.120 | Urologic Neoplasms | NA | CTD_human | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.002 | Uterine Neoplasms | NA | GAD | Detail | |
0.004 | Fibromatosis, Aggressive | NA | BeFree,LHGDN | Detail | |
0.020 | B-Cell Lymphomas | Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin's lymphoma ... | BeFree,GAD,LHGDN | 24166616 | Detail |
<0.001 | High Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
0.006 | diffuse large B-cell lymphoma | Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation an... | BeFree,GAD | 25596256 | Detail |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | Precursor cell lymphoblastic lymphoma | NA | BeFree | Detail | |
<0.001 | Diffuse Mixed-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
0.003 | Lymphoma, T-Cell, Cutaneous | NA | BeFree,LHGDN | Detail | |
<0.001 | peripheral T-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Peripheral Vascular Diseases | NA | BeFree | Detail | |
<0.001 | cerebral amyloid angiopathy | NA | BeFree | Detail | |
<0.001 | Alcohol abuse | NA | BeFree | Detail | |
<0.001 | benign neoplasm | NA | BeFree | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Oral Cavity Carcinoma | NA | BeFree | Detail | |
0.120 | Myocardial Ischemia | NA | CTD_human | Detail | |
0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | Furthermore, suppressed CCND1 and elevated caspase3 and caspase7 expression leve... | BeFree | 24972691 | Detail |
<0.001 | Adenocarcinoma of lung (disorder) | Furthermore, HMC-1 exosomes contain and transfer KIT protein, but not the c-KIT ... | BeFree | 25311367 | Detail |
0.007 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of tongue | The increased expression of pS(21)GSK3α and pS(9)GSK3β not only correlated posit... | BeFree | 25645517 | Detail |
0.014 | Malignant neoplasm of mouth | We used the odds ratio (OR) and hazard ratio (HR) as the common measures of asso... | BeFree,GAD | 24675814 | Detail |
0.014 | Malignant neoplasm of mouth | The expression of total and phosphorylated GSK3α/β as well as cyclin D1 and p53 ... | BeFree,GAD | 25645517 | Detail |
<0.001 | Malignant neoplasm of nasopharynx | NA | BeFree | Detail | |
<0.001 | uterine cancer | NA | BeFree | Detail | |
<0.001 | Malignant tumor of parathyroid gland | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | adrenoleukodystrophy | NA | BeFree | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
<0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
0.008 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | follicular adenoma | NA | BeFree | Detail | |
<0.001 | Undifferentiated carcinoma | NA | BeFree | Detail | |
<0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
<0.001 | Liposarcoma, Dedifferentiated | NA | BeFree | Detail | |
<0.001 | Germ cell tumor | NA | BeFree | Detail | |
<0.001 | Sarcoma, Epithelioid | NA | BeFree | Detail | |
<0.001 | thymic carcinoma | NA | BeFree | Detail | |
<0.001 | Lichen Planus, Oral | NA | BeFree | Detail | |
<0.001 | Ki-1+ Anaplastic Large Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | adenomyoma | NA | BeFree | Detail | |
0.003 | hepatoblastoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Mesoblastic Nephroma | Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and meta... | BeFree | 25751590 | Detail |
0.001 | endometrial stromal sarcoma | Furthermore, YWHAE-NUTM2 ESSs are strongly cyclin D1 positive in contrast to con... | BeFree | 25244606 | Detail |
0.001 | endometrial stromal sarcoma | This translocation also occurs in high-grade endometrial sarcoma, in which it is... | BeFree | 25751590 | Detail |
<0.001 | Giant Cell Tumor of Bone | NA | BeFree | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma | NA | BeFree | Detail | |
<0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
0.007 | cholangiocarcinoma | NA | BeFree,LHGDN | Detail | |
0.003 | verrucous carcinoma | NA | LHGDN | Detail | |
<0.001 | pilomatrixoma | NA | BeFree | Detail | |
0.003 | Squamous Cell Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | hemangioblastoma | NA | BeFree | Detail | |
<0.001 | Nevus, Blue | NA | BeFree | Detail | |
<0.001 | Epithelioid and spindle cell nevus | NA | BeFree | Detail | |
0.003 | Rhabdoid Tumor | Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and meta... | BeFree,LHGDN | 25751590 | Detail |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | Nevi and Melanomas | NA | BeFree | Detail | |
<0.001 | uveal melanoma | Collectively, our results indicate that let-7b overexpression can in turn downre... | BeFree | 25588203 | Detail |
0.005 | Lip and oral cavity carcinoma | We used the odds ratio (OR) and hazard ratio (HR) as the common measures of asso... | BeFree | 24675814 | Detail |
0.005 | Lip and oral cavity carcinoma | The expression of total and phosphorylated GSK3α/β as well as cyclin D1 and p53 ... | BeFree | 25645517 | Detail |
0.001 | Hyperparathyroidism, Primary | NA | BeFree | Detail | |
<0.001 | Comedone | NA | BeFree | Detail | |
<0.001 | Chondromyxoid fibroma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of female breast | NA | BeFree | Detail | |
0.007 | pancreatic carcinoma | MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lin... | BeFree | 24608432 | Detail |
0.007 | pancreatic carcinoma | WNT5A, p-AKT and Cyclin D1 were highly expressed in pancreatic cancer tissues, a... | BeFree | 25308364 | Detail |
0.007 | pancreatic carcinoma | Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analy... | BeFree | 25470788 | Detail |
<0.001 | Carcinoma of extrahepatic bile duct | NA | BeFree | Detail | |
<0.001 | Carcinoma of male breast | NA | BeFree | Detail | |
<0.001 | Gastrointestinal Stromal Tumors | NA | BeFree | Detail | |
0.003 | Cancer of Nasopharynx | NA | BeFree,GAD | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
0.002 | Papillary thyroid carcinoma | A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary... | BeFree | 25227811 | Detail |
0.068 | breast carcinoma | We retrospectively evaluated the association of SNPs in DNA repair genes, XRCC1-... | BeFree | 17116943 | Detail |
<0.001 | Dyslipidemias | A multivariate analysis revealed that the NR3C1 Bcl1 G allele was a significant ... | BeFree | 25944971 | Detail |
0.106 | Malignant neoplasm of breast | We retrospectively evaluated the association of SNPs in DNA repair genes, XRCC1-... | BeFree | 17116943 | Detail |
0.080 | Erectile dysfunction | NA | RGD | Detail | |
0.024 | Malignant neoplasm of lung | Recently, we demonstrated that PML interacted with nuclear EGFR (nEGFR) and supp... | BeFree,GAD | 25486572 | Detail |
0.024 | Malignant neoplasm of lung | These effects may result from the ability of miR-5100 to promote G1/S transition... | BeFree,GAD | 25754817 | Detail |
0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
0.003 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of male breast | NA | BeFree | Detail | |
<0.001 | Proliferative vitreoretinopathy | The purpose of this study was to identify interacting signaling pathways by whic... | BeFree | 26247679 | Detail |
<0.001 | Carcinoma, Small Cell | NA | BeFree | Detail | |
0.007 | parathyroid adenoma | NA | BeFree | Detail | |
<0.001 | Isovaleryl-CoA dehydrogenase deficiency | NA | BeFree | Detail | |
<0.001 | Parathyroid hyperplasia | NA | BeFree | Detail | |
<0.001 | Erythroblastosis | NA | BeFree | Detail | |
<0.001 | Virchow's node (disorder) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Non-small cell lung cancer stage III | NA | BeFree | Detail | |
<0.001 | Disseminated neuroblastoma | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
0.006 | Cancer of Head and Neck | Cyclin D1-induced proliferation is independent of beta-catenin in head and neck ... | BeFree,GAD | 23730900 | Detail |
0.006 | Cancer of Head and Neck | Association of cyclin D1 variants with head and neck cancer susceptibility: evid... | BeFree,GAD | 25081680 | Detail |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
0.001 | Invasive lobular breast carcinoma | NA | BeFree | Detail | |
0.128 | Squamous cell carcinoma of esophagus | Cyclin D1 level correlated with Pin1 expression in clinical ESCC specimens. | BeFree,CTD_human | 25160749 | Detail |
0.002 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | gallbladder adenocarcinoma | The expressions of p21, p27, bcl-2, bcl-6 and cyclin D1 were not significant pro... | BeFree | 24178677 | Detail |
0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | bladder squamous cell carcinoma | Given that the tumor-promoting inflammation has been previously established in s... | BeFree | 24448750 | Detail |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Adenoid cystic carcinoma of salivary gland | NA | BeFree | Detail | |
0.003 | Solid tumour | NA | BeFree | Detail | |
<0.001 | stage, Kaposi's sarcoma | NA | BeFree | Detail | |
<0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
0.005 | laryngeal squamous cell carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Squamous cell carcinoma of vulva | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | Bone Marrow Neoplasms | NA | BeFree | Detail | |
<0.001 | Prostatic Intraepithelial Neoplasias | NA | BeFree | Detail | |
0.011 | cervix carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Senile Plaques | NA | BeFree | Detail | |
<0.001 | High-Grade Squamous Intraepithelial Lesions | NA | BeFree | Detail | |
<0.001 | inflammatory myofibroblastic tumor | NA | BeFree | Detail | |
<0.001 | Fibrolamellar hepatocellular carcinoma | NA | BeFree | Detail | |
<0.001 | Superficial spreading malignant melanoma of skin | NA | BeFree | Detail | |
<0.001 | Clear cell sarcoma of kidney | Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kid... | BeFree | 25751590 | Detail |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
0.001 | Malignant lymphoma - lymphoplasmacytic | NA | BeFree | Detail | |
0.343 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin's lymphoma ... | BeFree,CTD_human,LHGDN,ORPHANET | 24166616 | Detail |
0.343 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | Fluorescence in situ hybridization in MCL cells showed that t(11;14)(q13;q32) re... | BeFree,CTD_human,LHGDN,ORPHANET | 24237447 | Detail |
0.343 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | Mantle cell lymphoma is molecularly characterized by the chromosomal translocati... | BeFree,CTD_human,LHGDN,ORPHANET | 24857076 | Detail |
0.343 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | Our study demonstrates convincingly that IGH-CCND1 rearrangement leading to cycl... | BeFree,CTD_human,LHGDN,ORPHANET | 25596256 | Detail |
0.343 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | Interestingly, depletion of JARID1B inhibits Cyclin D1, which is one of the gene... | BeFree,CTD_human,LHGDN,ORPHANET | 25755704 | Detail |
<0.001 | Malignant lymphomatous polyposis | NA | BeFree | Detail | |
<0.001 | Endometrial Stromal Tumors | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
<0.001 | Proliferative retinopathy | Since cyclin D1 is a key regulator of cell cycle G1/S phase progression essentia... | BeFree | 26247679 | Detail |
<0.001 | Jaw Keratocyst | NA | BeFree | Detail | |
<0.001 | Human papilloma virus infection | NA | BeFree | Detail | |
<0.001 | Cerebellar decompression injury | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of liver | NA | BeFree,GAD | Detail | |
<0.001 | intrahepatic cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Stage 0 Skin Melanoma | NA | BeFree | Detail | |
<0.001 | Breast Cancer, Familial | NA | BeFree | Detail | |
<0.001 | Vulval intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Oncocytoma, renal | NA | BeFree | Detail | |
0.003 | pituitary carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Malignant melanoma of ciliary body | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | Analyses of human colon cancer databases also demonstrated a link between miR26b... | BeFree | 24785257 | Detail |
<0.001 | Malignant neoplasm of large intestine | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of pancreas | MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lin... | BeFree | 24608432 | Detail |
0.007 | Malignant neoplasm of pancreas | WNT5A, p-AKT and Cyclin D1 were highly expressed in pancreatic cancer tissues, a... | BeFree | 25308364 | Detail |
0.007 | Malignant neoplasm of pancreas | Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analy... | BeFree | 25470788 | Detail |
<0.001 | Cervical intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of tongue | NA | BeFree | Detail | |
<0.001 | Richter's syndrome | NA | BeFree | Detail | |
0.002 | Splenic Marginal Zone B-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Pre B-cell acute lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.017 | Malignant neoplasm of prostate | The expression of prostate cancer-associated genes, including cyclin D1, IL-6, C... | BeFree,GAD | 25243457 | Detail |
0.017 | Malignant neoplasm of prostate | Formononetin could exhibit inhibitory activity against human prostate cancer cel... | BeFree,GAD | 25301361 | Detail |
0.017 | Malignant neoplasm of prostate | Moreover, our data suggest that TRAF6-mediated Lys63-linked ubiquitination of th... | BeFree,GAD | 25622187 | Detail |
0.017 | Malignant neoplasm of prostate | Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis ... | BeFree,GAD | 25888980 | Detail |
0.002 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
<0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
<0.001 | Hemimegalencephaly | NA | BeFree | Detail | |
0.001 | Trisomy 12 | NA | BeFree | Detail | |
<0.001 | Trisomy 11 | NA | BeFree | Detail | |
<0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma of spleen | NA | BeFree | Detail | |
<0.001 | Low grade B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Plasma cell tumor, malignant | NA | BeFree | Detail | |
<0.001 | Leukemia, Prolymphocytic, B-Cell | NA | BeFree | Detail | |
0.005 | endometrial carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Metabolic syndrome X | NA | BeFree | Detail | |
<0.001 | mantle lymphoma | NA | BeFree | Detail | |
0.027 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
0.002 | Thyroid carcinoma | Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we obser... | BeFree | 25854169 | Detail |
<0.001 | Ewings sarcoma | Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1... | BeFree | 25015333 | Detail |
<0.001 | Oropharyngeal disorders | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of skin | NA | BeFree | Detail | |
0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma - lymphocytic, intermediate differentiation | NA | BeFree | Detail | |
<0.001 | tongue carcinoma | CCND1 and DACT3 overexpression in non-habits associated tongue carcinomas were s... | BeFree | 24809775 | Detail |
<0.001 | tongue carcinoma | The increased expression of pS(21)GSK3α and pS(9)GSK3β not only correlated posit... | BeFree | 25645517 | Detail |
0.003 | Osteosarcoma of bone | β-catenin protein expression was, however, detected in the membrane and cytoplas... | BeFree | 24942472 | Detail |
0.003 | Osteosarcoma of bone | When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was dow... | BeFree | 25530340 | Detail |
0.003 | Osteosarcoma of bone | The cyclin D1 expression was significantly decreased following the treatment wit... | BeFree | 26434118 | Detail |
0.002 | Carcinoma of larynx | NA | BeFree | Detail | |
0.046 | Carcinogenesis | Western blotting analysis demonstrated that tumorigenesis related protein cyclin... | BeFree | 25120782 | Detail |
0.046 | Carcinogenesis | Cyclin D1 (CCND1) and E-cadherin (CDH1) are two important genes of the β-catenin... | BeFree | 25146682 | Detail |
0.046 | Carcinogenesis | AP-1 transcriptional activity was analyzed with a luciferase reporter and biolum... | BeFree | 25260534 | Detail |
0.046 | Carcinogenesis | This study aimed to investigate the correlation of RKIP, STAT3 and cyclin D1 exp... | BeFree | 25337233 | Detail |
0.046 | Carcinogenesis | The biological mechanism of CCND1 in carcinogenesis has not been fully examined;... | BeFree | 25470788 | Detail |
0.046 | Carcinogenesis | Cyclin D1 (CCND1) regulating cell cycle transition may determine the susceptible... | BeFree | 25809706 | Detail |
0.046 | Carcinogenesis | Cyclin D1 (CCND1) is critical in the transition of the cell cycle from the G1 to... | BeFree | 25888980 | Detail |
0.046 | Carcinogenesis | Aberrant nuclear β-catenin expression, detected in all MSTs, appears to be the r... | BeFree | 26200099 | Detail |
0.046 | Carcinogenesis | This study was performed to screen cyclin D1 (CCND1) and cyclin dependent kinase... | BeFree | 26416047 | Detail |
0.002 | Leukemogenesis | Furthermore, we demonstrate that PRMT5 overexpression specifically cooperates wi... | BeFree | 25582697 | Detail |
<0.001 | Lymphoid neoplasm | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.011 | prostate carcinoma | Cyclin D1 expression in prostate carcinoma. | BeFree | 24820071 | Detail |
0.011 | prostate carcinoma | The expression of prostate cancer-associated genes, including cyclin D1, IL-6, C... | BeFree | 25243457 | Detail |
0.011 | prostate carcinoma | Formononetin could exhibit inhibitory activity against human prostate cancer cel... | BeFree | 25301361 | Detail |
0.011 | prostate carcinoma | Moreover, our data suggest that TRAF6-mediated Lys63-linked ubiquitination of th... | BeFree | 25622187 | Detail |
0.011 | prostate carcinoma | Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis ... | BeFree | 25888980 | Detail |
<0.001 | CARCINOMA OF VULVA | NA | BeFree | Detail | |
0.005 | Epithelial ovarian cancer | miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progre... | BeFree,GAD | 25889927 | Detail |
0.005 | Epithelial ovarian cancer | The cyclin D1 expression was significantly decreased following the treatment wit... | BeFree,GAD | 26434118 | Detail |
<0.001 | invasive cancer | NA | BeFree | Detail | |
0.068 | breast carcinoma | Here, we demonstrate that two different ERβ agonists, WAY-20070 and a novel A-CD... | BeFree | 24785256 | Detail |
0.068 | breast carcinoma | Cyclin D1/CDK4 activity is upregulated in up to 50% of breast cancers and CDK4-m... | BeFree | 25006666 | Detail |
0.068 | breast carcinoma | Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant ... | BeFree | 25200445 | Detail |
0.068 | breast carcinoma | We found that TBLR1 expression was implicated in the upregulation of cyclin D1, ... | BeFree | 25341494 | Detail |
0.068 | breast carcinoma | Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA... | BeFree | 25363551 | Detail |
0.068 | breast carcinoma | Genetic association between cyclin D1 polymorphism and breast cancer susceptibil... | BeFree | 25399071 | Detail |
0.068 | breast carcinoma | Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast... | BeFree | 25657113 | Detail |
0.068 | breast carcinoma | We initiated the following study to directly test the oncogenic potential of cat... | BeFree | 25940700 | Detail |
0.068 | breast carcinoma | Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associat... | BeFree | 26416047 | Detail |
0.012 | Carcinoma of lung | Recently, we demonstrated that PML interacted with nuclear EGFR (nEGFR) and supp... | BeFree | 25486572 | Detail |
0.012 | Carcinoma of lung | These effects may result from the ability of miR-5100 to promote G1/S transition... | BeFree | 25754817 | Detail |
0.010 | Secondary malignant neoplasm of lymph node | In addition, amplification of CCND1 shows a negative predictive value of 80 % in... | BeFree | 25663615 | Detail |
0.002 | Parathyroid Gland Adenocarcinoma | Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadi... | BeFree | 24510244 | Detail |
<0.001 | extranodal lymphoma | NA | BeFree | Detail | |
0.010 | colon carcinoma | Analyses of human colon cancer databases also demonstrated a link between miR26b... | BeFree | 24785257 | Detail |
0.010 | colon carcinoma | Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer... | BeFree | 25229241 | Detail |
0.011 | stomach carcinoma | In conclusion, this CagA- PI3K/AKT-Sp1-RBP2-Cyclin D1 pathway may serve as a nov... | BeFree,GAD | 25015565 | Detail |
0.011 | stomach carcinoma | Western blot revealed that cyclin D1 and Bcl-2 expression were downregulated whe... | BeFree,GAD | 25060631 | Detail |
0.011 | stomach carcinoma | To examine the expression patterns of ER-α36 and Cyclin D1 in human gastric canc... | BeFree,GAD | 25231129 | Detail |
0.011 | stomach carcinoma | Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric c... | BeFree,GAD | 25337233 | Detail |
0.011 | stomach carcinoma | HIF2α is associated with poor prognosis and affects the expression levels of sur... | BeFree,GAD | 25338835 | Detail |
0.011 | stomach carcinoma | Moreover, the expression of WISP3 was positively correlated with the expression ... | BeFree,GAD | 25400723 | Detail |
0.011 | stomach carcinoma | Fz2 shRNA suppressed cell proliferation and motility of MKN45 and MKN74 cells, a... | BeFree,GAD | 25586465 | Detail |
0.011 | Carcinoma of bladder | Given that the tumor-promoting inflammation has been previously established in s... | BeFree,GAD | 24448750 | Detail |
0.011 | Carcinoma of bladder | All the results demonstrated that miR-576-3p might be a novel suppressor of blad... | BeFree,GAD | 25556372 | Detail |
0.011 | Carcinoma of bladder | Suppression of PHLPP2 or FOXO1 by miR-135a, consisted with dysregulation of p21,... | BeFree,GAD | 25888950 | Detail |
0.003 | skin carcinoma | NA | BeFree,GAD | Detail | |
0.003 | Central neuroblastoma | Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other... | BeFree | 25751590 | Detail |
0.004 | Malignant neoplasm of kidney | NA | BeFree,GAD | Detail | |
<0.001 | Premenopausal breast cancer | NA | BeFree | Detail | |
<0.001 | Pharyngeal Carcinoma | CCND1 amplification was significantly more frequent in pharyngeal carcinomas (63... | BeFree | 23494454 | Detail |
<0.001 | psychosocial stressor | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | lymphangioleiomyomatosis | NA | BeFree | Detail | |
0.002 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
<0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
<0.001 | Aicardi-Goutieres syndrome 1 | NA | BeFree | Detail | |
<0.001 | Adenomatous polyp of colon | NA | BeFree | Detail | |
0.002 | Invasive breast carcinoma | Cyclin D1 is a cell cycle regulatory gene emerging as a potentially significant ... | BeFree | 25313758 | Detail |
<0.001 | Bile duct cancer resectable | NA | BeFree | Detail | |
<0.001 | Synovial sarcoma metastatic | NA | BeFree | Detail | |
0.003 | Small Lymphocytic Lymphoma | NA | BeFree | Detail | |
<0.001 | Mantle cell lymphoma refractory | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
<0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Gastric hyperplastic polyp | NA | BeFree | Detail | |
0.091 | ovarian neoplasm | NA | BeFree,LHGDN,RGD | Detail | |
<0.001 | cancer recurrence | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
0.001 | Hurthle Cell Tumor | NA | BeFree | Detail | |
0.002 | Gastrooesophageal cancer | NA | GAD | Detail | |
0.002 | Invasive Ductal Breast Carcinoma | In this study, we attempted to see the expression of Cyclin D1 in invasive ducta... | BeFree | 25313758 | Detail |
<0.001 | Stage 4S neuroblastoma | NA | BeFree | Detail | |
<0.001 | Plasma cell dyscrasia | NA | BeFree | Detail | |
0.012 | Malignant neoplasm of ovary | The down regulation of β-catenin and cyclin-D1 in the tumor tissues may refer to... | BeFree,GAD | 24444073 | Detail |
<0.001 | endometrial adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Skin toxicity | NA | BeFree | Detail | |
0.016 | Squamous cell carcinoma of the head and neck | CCND1 amplification and cyclin D1 immunohistochemical expression in head and nec... | BeFree,GAD | 23494454 | Detail |
0.016 | Squamous cell carcinoma of the head and neck | The current study aims to investigate whether there is a crosstalk between these... | BeFree,GAD | 23730900 | Detail |
0.016 | Squamous cell carcinoma of the head and neck | These findings demonstrate that TRUE gene silencing of cyclin D1 leads to inhibi... | BeFree,GAD | 25437003 | Detail |
0.001 | Ductal Carcinoma | Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a signi... | BeFree | 25313758 | Detail |
0.005 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | large cell neuroendocrine carcinoma | NA | BeFree | Detail | |
<0.001 | chromophobe renal cell carcinoma | NA | BeFree | Detail | |
<0.001 | Collecting Duct Carcinoma of the Kidney | NA | BeFree | Detail | |
<0.001 | metanephric adenoma | Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and meta... | BeFree | 25751590 | Detail |
0.003 | Solitary fibrous tumor | NA | LHGDN | Detail | |
<0.001 | Atypical teratoid/rhabdoid tumor | NA | BeFree | Detail | |
<0.001 | Cutaneous lymphoma | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | atypical polypoid adenomyoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, Primary Cutaneous Anaplastic Large Cell | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
0.001 | chronic lymphocytic leukemia/small lymphocytic lymphoma | NA | BeFree | Detail | |
<0.001 | ACTH-secreting pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Liver regeneration disorder | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Anterior Tongue Carcinoma | Thus, CCND1 overexpression in non-habits associated anterior tongue carcinomas m... | BeFree | 24809775 | Detail |
<0.001 | Atypical Ductal Breast Hyperplasia | NA | BeFree | Detail | |
<0.001 | congenital mesoblastic nephroma | Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and meta... | BeFree | 25751590 | Detail |
<0.001 | Childhood Renal Neoplasm | Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other... | BeFree | 25751590 | Detail |
<0.001 | Gastric Precancerous Condition | NA | BeFree | Detail | |
0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
0.002 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | Low Grade Ductal Breast Carcinoma In Situ | NA | BeFree | Detail | |
<0.001 | Mature B-Cell Non-Hodgkin Lymphoma | NA | BeFree | Detail | |
0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Primary Carcinoma | NA | BeFree | Detail | |
<0.001 | Solid pseudopapillary tumour of the pancreas | NA | BeFree | Detail | |
<0.001 | Testicular Germ Cell Tumor | NA | BeFree | Detail | |
0.001 | Marginal Zone B-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Burkitt-like lymphoma | NA | BeFree | Detail | |
0.002 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Primary Lesion | NA | BeFree | Detail | |
0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Benign melanocytic nevus | NA | BeFree | Detail | |
0.193 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Breast Cancer Model | NA | BeFree | Detail | |
0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
0.001 | Mammary Tumorigenesis | Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumo... | BeFree | 25940700 | Detail |
<0.001 | Cancer Cell Growth | Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we obser... | BeFree | 25854169 | Detail |
<0.001 | Malignant Conversion | NA | BeFree | Detail | |
0.001 | Skin Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.068 | colorectal cancer | The elevated expression of ATG4B was highly correlated with CCND1 expression, co... | BeFree,GAD | 24991826 | Detail |
0.068 | colorectal cancer | Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorecta... | BeFree,GAD | 25146682 | Detail |
0.068 | colorectal cancer | Treatment with ganetespib (50 nM) for 24 hours inhibited cyclin D1 and pRb at th... | BeFree,GAD | 25296971 | Detail |
0.068 | colorectal cancer | Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of t... | BeFree,GAD | 25479723 | Detail |
0.068 | colorectal cancer | The significant association of CCND1 genotypes with colorectal cancer in Taiwan. | BeFree,GAD | 25809706 | Detail |
0.068 | colorectal cancer | Additionally, CCND1 (cyclin D1), and PTGS2 (prostaglandin-endoperoxide synthase ... | BeFree,GAD | 25818893 | Detail |
0.068 | colorectal cancer | The quantitative level of the β-catenin protein was significantly decreased in t... | BeFree,GAD | 26316447 | Detail |
<0.001 | Ductal Breast Carcinoma | Cyclin D1 expression in ductal carcinoma of the breast and its correlation with ... | BeFree | 25313758 | Detail |
<0.001 | Ductal Breast Carcinoma | The biological mechanism of CCND1 in carcinogenesis has not been fully examined;... | BeFree | 25470788 | Detail |
<0.001 | smoldering myeloma | NA | BeFree | Detail | |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
<0.001 | Peripheral Arterial Diseases | NA | BeFree | Detail | |
<0.001 | Keratocystic Odontogenic Tumor | Overexpression of upstream (PTCH1 and SMO) and downstream (GLI1, CCND1 and BCL2)... | BeFree | 24930892 | Detail |
0.397 | multiple myeloma | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multip... | GWASCAT | 23502783 | Detail |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Papillary Thyroid Microcarcinoma | NA | BeFree | Detail | |
<0.001 | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | Solely the expression of cyclin D1 (100%) and the presence of t(11;14) (100%) al... | BeFree | 26034867 | Detail |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
0.003 | Idiopathic Pulmonary Fibrosis | NA | BeFree,LHGDN | Detail | |
<0.001 | MYELOPROLIFERATIVE SYNDROME, TRANSIENT | Aberrant nuclear β-catenin expression, detected in all MSTs, appears to be the r... | BeFree | 26200099 | Detail |
<0.001 | Hyperparathyroidism 1 | NA | BeFree | Detail | |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
<0.001 | ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | NA | BeFree | Detail | |
<0.001 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | NA | BeFree | Detail | |
<0.001 | TUBEROUS SCLEROSIS 2 (disorder) | NA | BeFree | Detail | |
<0.001 | HYPERPARATHYROIDISM 3 | NA | BeFree | Detail | |
0.002 | uterine corpus cancer | NA | BeFree | Detail | |
<0.001 | Lymphoma, Follicular, Grade 1 | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
0.003 | Cardiac Carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | plasma cell neoplasm | NA | BeFree | Detail | |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
0.007 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD | Detail | |
0.004 | Leukemia, B-Cell | NA | BeFree,LHGDN | Detail | |
<0.001 | Urothelial Carcinoma | Given that the tumor-promoting inflammation has been previously established in s... | BeFree | 24448750 | Detail |
<0.001 | malignant neoplasm of breast staging | NA | BeFree | Detail | |
0.147 | liver carcinoma | The bFGF-stimulated activation of protein kinase B (AKT) and extracellular signa... | BeFree,CTD_human,GAD,LHGDN | 24970807 | Detail |
0.147 | liver carcinoma | Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibit... | BeFree,CTD_human,GAD,LHGDN | 25015194 | Detail |
0.147 | liver carcinoma | Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular c... | BeFree,CTD_human,GAD,LHGDN | 25109821 | Detail |
0.147 | liver carcinoma | In addition, these findings were further strengthened by results showing that ex... | BeFree,CTD_human,GAD,LHGDN | 25313882 | Detail |
0.147 | liver carcinoma | Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells... | BeFree,CTD_human,GAD,LHGDN | 25385370 | Detail |
0.147 | liver carcinoma | Both sorafenib and ATO downregulated the expression of cyclin D1, resulting in H... | BeFree,CTD_human,GAD,LHGDN | 25416439 | Detail |
<0.001 | Endometrial stromal sarcoma, high grade | NA | BeFree | Detail | |
<0.001 | bulimia nervosa | NA | BeFree | Detail | |
<0.001 | Oropharyngeal Carcinoma | NA | BeFree | Detail | |
<0.001 | Adrenal incidentaloma | NA | BeFree | Detail | |
<0.001 | Steatohepatitis | NA | BeFree | Detail | |
<0.001 | Lentigo maligna melanoma | NA | BeFree | Detail | |
<0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | NA | BeFree | Detail | |
0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
0.125 | Nasopharyngeal carcinoma | Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in r... | BeFree,CTD_human | 25109634 | Detail |
0.125 | Nasopharyngeal carcinoma | Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-contro... | BeFree,CTD_human | 25409185 | Detail |
<0.001 | Clear-cell metastatic renal cell carcinoma | NA | BeFree | Detail | |
0.002 | Prostatic Hyperplasia | NA | GAD | Detail | |
<0.001 | Endometrial sarcoma | This translocation also occurs in high-grade endometrial sarcoma, in which it is... | BeFree | 25751590 | Detail |
<0.001 | Bisphosphonate-associated osteonecrosis | NA | BeFree | Detail | |
<0.001 | Early-Stage Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Esophageal Spindle Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Palisaded myofibroblastoma | NA | BeFree | Detail | |
0.003 | myelodysplastic syndrome | NA | LHGDN | Detail | |
<0.001 | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | NA | BeFree | Detail | |
<0.001 | Melanocytic nevus of skin | NA | BeFree | Detail | |
<0.001 | Mammary adenocarcinoma | Sustained expression of cyclin D1(KE) induced mammary adenocarcinoma with simila... | BeFree | 25940700 | Detail |
<0.001 | Fibromyxosarcoma | NA | BeFree | Detail | |
0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Apert syndrome | NA | BeFree | Detail | |
0.024 | adenocarcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.011 | adenoma | Western blot and immunohistochemical analysis also demonstrated higher expressio... | BeFree,LHGDN | 24510244 | Detail |
<0.001 | Alzheimer's disease | Cyclin D1 positive neurons are colocalized with AGEs or directly surrounded by e... | BeFree | 25448604 | Detail |
<0.001 | ameloblastoma | Overexpression of upstream (PTCH1 and SMO) and downstream (GLI1, CCND1 and BCL2)... | BeFree | 24930892 | Detail |
<0.001 | Anaplasia | NA | BeFree | Detail | |
0.003 | Anoxia | NA | LHGDN | Detail | |
<0.001 | Anus Neoplasms | NA | BeFree | Detail | |
<0.001 | Anxiety Disorders | NA | BeFree | Detail | |
<0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | asthma | Bcl1 polymorphism of glucocorticoids receptor gene and bronchial asthma. | BeFree | 25879559 | Detail |
0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
0.003 | Barrett esophagus | NA | BeFree,GAD | Detail | |
<0.001 | Basal Cell Nevus Syndrome | NA | BeFree | Detail | |
<0.001 | Benign Ovarian Neoplasm | NA | BeFree | Detail | |
0.027 | Malignant neoplasm of urinary bladder | All the results demonstrated that miR-576-3p might be a novel suppressor of blad... | BeFree,GAD | 25556372 | Detail |
0.027 | Malignant neoplasm of urinary bladder | Suppression of PHLPP2 or FOXO1 by miR-135a, consisted with dysregulation of p21,... | BeFree,GAD | 25888950 | Detail |
0.010 | Bladder Neoplasm | NA | BeFree,GAD,LHGDN | Detail | |
0.123 | Brain Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
0.106 | Malignant neoplasm of breast | Here, we demonstrate that two different ERβ agonists, WAY-20070 and a novel A-CD... | BeFree,GAD | 24785256 | Detail |
0.106 | Malignant neoplasm of breast | Cyclin D1/CDK4 activity is upregulated in up to 50% of breast cancers and CDK4-m... | BeFree,GAD | 25006666 | Detail |
0.106 | Malignant neoplasm of breast | Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant ... | BeFree,GAD | 25200445 | Detail |
0.106 | Malignant neoplasm of breast | The high or moderate expressions of breast cancer markers (VEGF, c-Myc and cycli... | BeFree,GAD | 25230850 | Detail |
0.106 | Malignant neoplasm of breast | We found that TBLR1 expression was implicated in the upregulation of cyclin D1, ... | BeFree,GAD | 25341494 | Detail |
0.106 | Malignant neoplasm of breast | Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA... | BeFree,GAD | 25363551 | Detail |
0.106 | Malignant neoplasm of breast | Genetic association between cyclin D1 polymorphism and breast cancer susceptibil... | BeFree,GAD | 25399071 | Detail |
0.106 | Malignant neoplasm of breast | Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast... | BeFree,GAD | 25657113 | Detail |
0.106 | Malignant neoplasm of breast | We initiated the following study to directly test the oncogenic potential of cat... | BeFree,GAD | 25940700 | Detail |
0.106 | Malignant neoplasm of breast | Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associat... | BeFree,GAD | 26416047 | Detail |
<0.001 | Burkitt lymphoma | NA | BeFree | Detail | |
0.009 | Malignant tumor of colon | Analyses of human colon cancer databases also demonstrated a link between miR26b... | BeFree | 24785257 | Detail |
0.009 | Malignant tumor of colon | Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer... | BeFree | 25229241 | Detail |
0.002 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | female breast carcinoma | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of larynx | NA | BeFree,GAD | Detail | |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we obser... | BeFree | 25854169 | Detail |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
0.004 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
0.011 | Non-small cell lung carcinoma | Interestingly, DDX5 and cyclin D1 expression followed positive correlation in th... | BeFree,GAD | 26212035 | Detail |
<0.001 | Carcinoma, Papillary | NA | BeFree | Detail | |
0.004 | renal cell carcinoma | The effect of downregulation of tNASP by siRNA on cell colony formation and prol... | BeFree | 25669170 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral sq... | DisGeNET | Detail |
Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the... | DisGeNET | Detail |
Given that the tumor-promoting inflammation has been previously established in squamous cell carcino... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The elevated expression of ATG4B was highly correlated with CCND1 expression, consistently supportin... | DisGeNET | Detail |
Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibil... | DisGeNET | Detail |
Treatment with ganetespib (50 nM) for 24 hours inhibited cyclin D1 and pRb at the transcriptional an... | DisGeNET | Detail |
Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in huma... | DisGeNET | Detail |
The significant association of CCND1 genotypes with colorectal cancer in Taiwan. | DisGeNET | Detail |
Additionally, CCND1 (cyclin D1), and PTGS2 (prostaglandin-endoperoxide synthase 2) have reported to ... | DisGeNET | Detail |
The quantitative level of the β-catenin protein was significantly decreased in the CRC cell lysates,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, the expression of Cav-1 was downregulated in CRS and the role of Cav-1 was impaired i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluv... | DisGeNET | Detail |
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluv... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mitotic index and immunoreactivity of NF-kB, phospho-IkB, and cyclin D1 in the center of 28 larg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also obser... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil b... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, we determined the expression patterns of connective tissue growth factor (CTGF) and cyc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Two cyclin D1-positive lymphomas with morphologic features of DLBCL and IGH-CCND1 translocations wer... | DisGeNET | Detail |
We present here a unique case of follicular lymphoma (FL) with rearranged BCL2, BCL6, and BCL1 (also... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, this CagA- PI3K/AKT-Sp1-RBP2-Cyclin D1 pathway may serve as a novel mechanism for gas... | DisGeNET | Detail |
To examine the expression patterns of ER-α36 and Cyclin D1 in human gastric cancer tissues and to in... | DisGeNET | Detail |
Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. | DisGeNET | Detail |
Moreover, the expression of WISP3 was positively correlated with the expression of cyclin D1 and TCF... | DisGeNET | Detail |
Fz2 shRNA suppressed cell proliferation and motility of MKN45 and MKN74 cells, and downregulated cyc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FISH analysis of human acral melanoma expanding in the epidermis revealed that unpigmented melanobla... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An association between CCND1 overexpression in oral tumors and poor prognosis has previously been re... | DisGeNET | Detail |
We showed tetraspanins attenuated peIF4E and its targets [c‑Myc, cyclin D1 (cycD1)]; eIF4E attenuati... | DisGeNET | Detail |
Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Head and neck squamous cell carcinoma (HNSCC) progression and metastasis have previously been associ... | DisGeNET | Detail |
The pooled results provided compelling evidence that cyclin D1 overexpression was significantly corr... | DisGeNET | Detail |
RKIP expression in gastric cancer was negatively correlated with the invasion, TNM stage and lymphoi... | DisGeNET | Detail |
To elucidate the underlying molecular mechanisms produced by these EDC, alterations in transcription... | DisGeNET | Detail |
Our results suggest that the CCND1 A870G polymorphism might not be a potential candidate for predict... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and metanephric adenoma and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other pediatric renal tum... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
β-catenin protein expression was, however, detected in the membrane and cytoplasm of 69.6% (32/46) o... | DisGeNET | Detail |
When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was downregulated in osteos... | DisGeNET | Detail |
The cyclin D1 expression was significantly decreased following the treatment with quercetin in SKOV3... | DisGeNET | Detail |
The down regulation of β-catenin and cyclin-D1 in the tumor tissues may refer to the inhibition of S... | DisGeNET | Detail |
The cyclin D1 expression was significantly decreased following the treatment with quercetin in SKOV3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Discordant results were observed for VEGFR1, p27, and p21 overexpressed in paragangliomas but undere... | DisGeNET | Detail |
NA | DisGeNET | Detail |
While bi-allelic inactivation of CDC73/HRPT2 seems unique to parathyroid malignancy, aberrant activa... | DisGeNET | Detail |
We observed that Ad-HDAC2 shRNA decreased inflammatory cell infiltration, reduced transnuclear expre... | DisGeNET | Detail |
Overexpression of the SMAD7 gene decreased the expression of cyclin D1 (a positive cell cycle regula... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Further studies in premalignant bronchial cells showed that the antiproliferative effects of I3C + S... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Following further examination of cell cycle-related factors, MCM2 knockdown inhibited protein retino... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RKIP, STAT3 and cyclin D1 proteins were detected by immunohistochemistry in tissues of gastric ulcer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin's lymphoma characterized by chr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, suppressed CCND1 and elevated caspase3 and caspase7 expression levels at mRNA were foun... | DisGeNET | Detail |
Furthermore, HMC-1 exosomes contain and transfer KIT protein, but not the c-KIT mRNA to A549 cells a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The increased expression of pS(21)GSK3α and pS(9)GSK3β not only correlated positively with cyclin D1... | DisGeNET | Detail |
We used the odds ratio (OR) and hazard ratio (HR) as the common measures of association to quantitat... | DisGeNET | Detail |
The expression of total and phosphorylated GSK3α/β as well as cyclin D1 and p53 together with their ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and metanephric adenoma and ... | DisGeNET | Detail |
Furthermore, YWHAE-NUTM2 ESSs are strongly cyclin D1 positive in contrast to conventional low-grade ... | DisGeNET | Detail |
This translocation also occurs in high-grade endometrial sarcoma, in which it is associated with cyc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and metanephric adenoma and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Collectively, our results indicate that let-7b overexpression can in turn downregulate cyclin D1 exp... | DisGeNET | Detail |
We used the odds ratio (OR) and hazard ratio (HR) as the common measures of association to quantitat... | DisGeNET | Detail |
The expression of total and phosphorylated GSK3α/β as well as cyclin D1 and p53 together with their ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lines induced a decreas... | DisGeNET | Detail |
WNT5A, p-AKT and Cyclin D1 were highly expressed in pancreatic cancer tissues, and the WNT5A express... | DisGeNET | Detail |
Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in t... | DisGeNET | Detail |
We retrospectively evaluated the association of SNPs in DNA repair genes, XRCC1-01 (Arg399Gln) and X... | DisGeNET | Detail |
A multivariate analysis revealed that the NR3C1 Bcl1 G allele was a significant risk factor for the ... | DisGeNET | Detail |
We retrospectively evaluated the association of SNPs in DNA repair genes, XRCC1-01 (Arg399Gln) and X... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, we demonstrated that PML interacted with nuclear EGFR (nEGFR) and suppressed the nEGFR-med... | DisGeNET | Detail |
These effects may result from the ability of miR-5100 to promote G1/S transition and downregulate cy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The purpose of this study was to identify interacting signaling pathways by which the activation of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1-induced proliferation is independent of beta-catenin in head and neck cancer. | DisGeNET | Detail |
Association of cyclin D1 variants with head and neck cancer susceptibility: evidence from a meta-ana... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 level correlated with Pin1 expression in clinical ESCC specimens. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expressions of p21, p27, bcl-2, bcl-6 and cyclin D1 were not significant prognostic factors for ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given that the tumor-promoting inflammation has been previously established in squamous cell carcino... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin's lymphoma characterized by chr... | DisGeNET | Detail |
Fluorescence in situ hybridization in MCL cells showed that t(11;14)(q13;q32) results in detachment ... | DisGeNET | Detail |
Mantle cell lymphoma is molecularly characterized by the chromosomal translocation t(11;14) (q13;q32... | DisGeNET | Detail |
Our study demonstrates convincingly that IGH-CCND1 rearrangement leading to cyclin D1 overexpression... | DisGeNET | Detail |
Interestingly, depletion of JARID1B inhibits Cyclin D1, which is one of the genes contributes to MCL... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Since cyclin D1 is a key regulator of cell cycle G1/S phase progression essential for proliferation,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analyses of human colon cancer databases also demonstrated a link between miR26b and LEF1 expression... | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lines induced a decreas... | DisGeNET | Detail |
WNT5A, p-AKT and Cyclin D1 were highly expressed in pancreatic cancer tissues, and the WNT5A express... | DisGeNET | Detail |
Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of prostate cancer-associated genes, including cyclin D1, IL-6, COX2, and ETV1, was b... | DisGeNET | Detail |
Formononetin could exhibit inhibitory activity against human prostate cancer cells in vivo and in vi... | DisGeNET | Detail |
Moreover, our data suggest that TRAF6-mediated Lys63-linked ubiquitination of the TβRI intracellular... | DisGeNET | Detail |
Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we observed that treatment o... | DisGeNET | Detail |
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCND1 and DACT3 overexpression in non-habits associated tongue carcinomas were subsequently validate... | DisGeNET | Detail |
The increased expression of pS(21)GSK3α and pS(9)GSK3β not only correlated positively with cyclin D1... | DisGeNET | Detail |
β-catenin protein expression was, however, detected in the membrane and cytoplasm of 69.6% (32/46) o... | DisGeNET | Detail |
When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was downregulated in osteos... | DisGeNET | Detail |
The cyclin D1 expression was significantly decreased following the treatment with quercetin in SKOV3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Western blotting analysis demonstrated that tumorigenesis related protein cyclin D1 and p21, as well... | DisGeNET | Detail |
Cyclin D1 (CCND1) and E-cadherin (CDH1) are two important genes of the β-catenin/LEF pathway that is... | DisGeNET | Detail |
AP-1 transcriptional activity was analyzed with a luciferase reporter and bioluminescence imaging, a... | DisGeNET | Detail |
This study aimed to investigate the correlation of RKIP, STAT3 and cyclin D1 expression in the tumor... | DisGeNET | Detail |
The biological mechanism of CCND1 in carcinogenesis has not been fully examined; but at present Cycl... | DisGeNET | Detail |
Cyclin D1 (CCND1) regulating cell cycle transition may determine the susceptible individuals to geno... | DisGeNET | Detail |
Cyclin D1 (CCND1) is critical in the transition of the cell cycle from the G1 to S phases, and unbal... | DisGeNET | Detail |
Aberrant nuclear β-catenin expression, detected in all MSTs, appears to be the result of stabilizing... | DisGeNET | Detail |
This study was performed to screen cyclin D1 (CCND1) and cyclin dependent kinases (CDK4) genes in or... | DisGeNET | Detail |
Furthermore, we demonstrate that PRMT5 overexpression specifically cooperates with cyclin D1 to driv... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 expression in prostate carcinoma. | DisGeNET | Detail |
The expression of prostate cancer-associated genes, including cyclin D1, IL-6, COX2, and ETV1, was b... | DisGeNET | Detail |
Formononetin could exhibit inhibitory activity against human prostate cancer cells in vivo and in vi... | DisGeNET | Detail |
Moreover, our data suggest that TRAF6-mediated Lys63-linked ubiquitination of the TβRI intracellular... | DisGeNET | Detail |
Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting C... | DisGeNET | Detail |
The cyclin D1 expression was significantly decreased following the treatment with quercetin in SKOV3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we demonstrate that two different ERβ agonists, WAY-20070 and a novel A-CD estrogen called L17... | DisGeNET | Detail |
Cyclin D1/CDK4 activity is upregulated in up to 50% of breast cancers and CDK4-mediated phosphorylat... | DisGeNET | Detail |
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with tr... | DisGeNET | Detail |
We found that TBLR1 expression was implicated in the upregulation of cyclin D1, phosphorylation of c... | DisGeNET | Detail |
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 ... | DisGeNET | Detail |
Genetic association between cyclin D1 polymorphism and breast cancer susceptibility. | DisGeNET | Detail |
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells. | DisGeNET | Detail |
We initiated the following study to directly test the oncogenic potential of catalytically inactive ... | DisGeNET | Detail |
Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associated with susceptibili... | DisGeNET | Detail |
Recently, we demonstrated that PML interacted with nuclear EGFR (nEGFR) and suppressed the nEGFR-med... | DisGeNET | Detail |
These effects may result from the ability of miR-5100 to promote G1/S transition and downregulate cy... | DisGeNET | Detail |
In addition, amplification of CCND1 shows a negative predictive value of 80 % in the detection of LN... | DisGeNET | Detail |
Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analyses of human colon cancer databases also demonstrated a link between miR26b and LEF1 expression... | DisGeNET | Detail |
Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer. | DisGeNET | Detail |
In conclusion, this CagA- PI3K/AKT-Sp1-RBP2-Cyclin D1 pathway may serve as a novel mechanism for gas... | DisGeNET | Detail |
Western blot revealed that cyclin D1 and Bcl-2 expression were downregulated whereas p27 and Bax wer... | DisGeNET | Detail |
To examine the expression patterns of ER-α36 and Cyclin D1 in human gastric cancer tissues and to in... | DisGeNET | Detail |
Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. | DisGeNET | Detail |
HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 ... | DisGeNET | Detail |
Moreover, the expression of WISP3 was positively correlated with the expression of cyclin D1 and TCF... | DisGeNET | Detail |
Fz2 shRNA suppressed cell proliferation and motility of MKN45 and MKN74 cells, and downregulated cyc... | DisGeNET | Detail |
Given that the tumor-promoting inflammation has been previously established in squamous cell carcino... | DisGeNET | Detail |
All the results demonstrated that miR-576-3p might be a novel suppressor of bladder cancer cell prol... | DisGeNET | Detail |
Suppression of PHLPP2 or FOXO1 by miR-135a, consisted with dysregulation of p21, p27, Cyclin D1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other pediatric renal tum... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCND1 amplification was significantly more frequent in pharyngeal carcinomas (63%) than in laryngeal... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 is a cell cycle regulatory gene emerging as a potentially significant oncogene in invasive... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this study, we attempted to see the expression of Cyclin D1 in invasive ductal carcinomas of the ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The down regulation of β-catenin and cyclin-D1 in the tumor tissues may refer to the inhibition of S... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carc... | DisGeNET | Detail |
The current study aims to investigate whether there is a crosstalk between these pathways in HNSCC a... | DisGeNET | Detail |
These findings demonstrate that TRUE gene silencing of cyclin D1 leads to inhibition of the growth o... | DisGeNET | Detail |
Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a significant correlation w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and metanephric adenoma and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, CCND1 overexpression in non-habits associated anterior tongue carcinomas may contribute to the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 immunohistochemistry helps distinguish CCSK from blastemal WT and metanephric adenoma and ... | DisGeNET | Detail |
Cyclin D1 immunohistochemistry was also performed on tissue microarrays of other pediatric renal tum... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. | DisGeNET | Detail |
Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we observed that treatment o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The elevated expression of ATG4B was highly correlated with CCND1 expression, consistently supportin... | DisGeNET | Detail |
Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibil... | DisGeNET | Detail |
Treatment with ganetespib (50 nM) for 24 hours inhibited cyclin D1 and pRb at the transcriptional an... | DisGeNET | Detail |
Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in huma... | DisGeNET | Detail |
The significant association of CCND1 genotypes with colorectal cancer in Taiwan. | DisGeNET | Detail |
Additionally, CCND1 (cyclin D1), and PTGS2 (prostaglandin-endoperoxide synthase 2) have reported to ... | DisGeNET | Detail |
The quantitative level of the β-catenin protein was significantly decreased in the CRC cell lysates,... | DisGeNET | Detail |
Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic par... | DisGeNET | Detail |
The biological mechanism of CCND1 in carcinogenesis has not been fully examined; but at present Cycl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of upstream (PTCH1 and SMO) and downstream (GLI1, CCND1 and BCL2) genes in the SHH pa... | DisGeNET | Detail |
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Solely the expression of cyclin D1 (100%) and the presence of t(11;14) (100%) allowed a distinction ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Aberrant nuclear β-catenin expression, detected in all MSTs, appears to be the result of stabilizing... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given that the tumor-promoting inflammation has been previously established in squamous cell carcino... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The bFGF-stimulated activation of protein kinase B (AKT) and extracellular signal-regulated kinase (... | DisGeNET | Detail |
Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) sup... | DisGeNET | Detail |
Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma. | DisGeNET | Detail |
In addition, these findings were further strengthened by results showing that expression of FZD7 was... | DisGeNET | Detail |
Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil b... | DisGeNET | Detail |
Both sorafenib and ATO downregulated the expression of cyclin D1, resulting in HCC cells arrested at... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasoph... | DisGeNET | Detail |
Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-ana... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This translocation also occurs in high-grade endometrial sarcoma, in which it is associated with cyc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sustained expression of cyclin D1(KE) induced mammary adenocarcinoma with similar kinetics to that o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Western blot and immunohistochemical analysis also demonstrated higher expression of CCND1 in carcin... | DisGeNET | Detail |
Cyclin D1 positive neurons are colocalized with AGEs or directly surrounded by extracellular AGE dep... | DisGeNET | Detail |
Overexpression of upstream (PTCH1 and SMO) and downstream (GLI1, CCND1 and BCL2) genes in the SHH pa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Bcl1 polymorphism of glucocorticoids receptor gene and bronchial asthma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
All the results demonstrated that miR-576-3p might be a novel suppressor of bladder cancer cell prol... | DisGeNET | Detail |
Suppression of PHLPP2 or FOXO1 by miR-135a, consisted with dysregulation of p21, p27, Cyclin D1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we demonstrate that two different ERβ agonists, WAY-20070 and a novel A-CD estrogen called L17... | DisGeNET | Detail |
Cyclin D1/CDK4 activity is upregulated in up to 50% of breast cancers and CDK4-mediated phosphorylat... | DisGeNET | Detail |
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with tr... | DisGeNET | Detail |
The high or moderate expressions of breast cancer markers (VEGF, c-Myc and cyclin D1) in mammary can... | DisGeNET | Detail |
We found that TBLR1 expression was implicated in the upregulation of cyclin D1, phosphorylation of c... | DisGeNET | Detail |
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 ... | DisGeNET | Detail |
Genetic association between cyclin D1 polymorphism and breast cancer susceptibility. | DisGeNET | Detail |
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells. | DisGeNET | Detail |
We initiated the following study to directly test the oncogenic potential of catalytically inactive ... | DisGeNET | Detail |
Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associated with susceptibili... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analyses of human colon cancer databases also demonstrated a link between miR26b and LEF1 expression... | DisGeNET | Detail |
Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1 and c-Myc are important regulators of cancer cell growth, and we observed that treatment o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, DDX5 and cyclin D1 expression followed positive correlation in the same set of NSCLC ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The effect of downregulation of tNASP by siRNA on cell colony formation and proliferation was examin... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg38
- Position
- chr11:69,641,156-69,654,474
- Variant Type
- snv
Genome browser